Nonhematologic adverse events
Event . | All patients (n = 59) . | Unknown . | Grade I . | Grade II . | Grade III . | Grade IV . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | |
Fever | 31 | 53 | 0 | 0 | 11 | 19 | 20 | 34 | 0 | 0 | 0 | 0 |
Asthenia | 20 | 34 | 0 | 0 | 19 | 32 | 1 | 2 | 0 | 0 | 0 | 0 |
Nausea | 20 | 34 | 0 | 0 | 18 | 31 | 1 | 2 | 1 | 2 | 0 | 0 |
Chills | 17 | 29 | 0 | 0 | 10 | 17 | 3 | 5 | 4 | 7 | 0 | 0 |
Infection | 13 | 22 | 2 | 3 | 9 | 15 | 2 | 3 | 0 | 0 | 0 | 0 |
Arthralgia | 13 | 22 | 1 | 2 | 11 | 19 | 1 | 2 | 0 | 0 | 0 | 0 |
Rash | 11 | 19 | 1 | 2 | 7 | 12 | 3 | 5 | 0 | 0 | 0 | 0 |
Pain | 9 | 15 | 0 | 0 | 9 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
Vomiting | 8 | 14 | 0 | 0 | 6 | 10 | 1 | 2 | 1 | 2 | 0 | 0 |
Urticaria | 8 | 14 | 0 | 0 | 3 | 5 | 5 | 8 | 0 | 0 | 0 | 0 |
Headache | 7 | 12 | 0 | 0 | 6 | 10 | 1 | 2 | 0 | 0 | 0 | 0 |
Myalgia | 7 | 12 | 1 | 2 | 6 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
Diarrhea | 6 | 10 | 0 | 0 | 5 | 8 | 0 | 0 | 1 | 2 | 0 | 0 |
Pharyngitis | 6 | 10 | 0 | 0 | 6 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
Pruritus | 6 | 10 | 0 | 0 | 5 | 8 | 1 | 2 | 0 | 0 | 0 | 0 |
Dizziness | 5 | 8 | 1 | 2 | 3 | 5 | 0 | 0 | 1 | 2 | 0 | 0 |
Urinary tract infection | 5 | 8 | 0 | 0 | 3 | 5 | 2 | 3 | 0 | 0 | 0 | 0 |
Abdominal pain | 4 | 7 | 0 | 0 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
Serum sickness | 4 | 7 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 5 | 0 | 0 |
Anorexia | 4 | 7 | 1 | 2 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Injection site reaction | 3 | 5 | 1 | 2 | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 0 |
Constipation | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Gastritis | 3 | 5 | 0 | 0 | 2 | 3 | 1 | 2 | 0 | 0 | 0 | 0 |
Hypothyroidism | 3 | 5 | 0 | 0 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 |
Paresthesia | 3 | 5 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cough increased | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Rhinitis | 3 | 5 | 0 | 0 | 2 | 3 | 1 | 2 | 0 | 0 | 0 | 0 |
Sweating | 3 | 5 | 0 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 0 | 0 |
Conjunctivitis | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Event . | All patients (n = 59) . | Unknown . | Grade I . | Grade II . | Grade III . | Grade IV . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | N . | % . | |
Fever | 31 | 53 | 0 | 0 | 11 | 19 | 20 | 34 | 0 | 0 | 0 | 0 |
Asthenia | 20 | 34 | 0 | 0 | 19 | 32 | 1 | 2 | 0 | 0 | 0 | 0 |
Nausea | 20 | 34 | 0 | 0 | 18 | 31 | 1 | 2 | 1 | 2 | 0 | 0 |
Chills | 17 | 29 | 0 | 0 | 10 | 17 | 3 | 5 | 4 | 7 | 0 | 0 |
Infection | 13 | 22 | 2 | 3 | 9 | 15 | 2 | 3 | 0 | 0 | 0 | 0 |
Arthralgia | 13 | 22 | 1 | 2 | 11 | 19 | 1 | 2 | 0 | 0 | 0 | 0 |
Rash | 11 | 19 | 1 | 2 | 7 | 12 | 3 | 5 | 0 | 0 | 0 | 0 |
Pain | 9 | 15 | 0 | 0 | 9 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
Vomiting | 8 | 14 | 0 | 0 | 6 | 10 | 1 | 2 | 1 | 2 | 0 | 0 |
Urticaria | 8 | 14 | 0 | 0 | 3 | 5 | 5 | 8 | 0 | 0 | 0 | 0 |
Headache | 7 | 12 | 0 | 0 | 6 | 10 | 1 | 2 | 0 | 0 | 0 | 0 |
Myalgia | 7 | 12 | 1 | 2 | 6 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
Diarrhea | 6 | 10 | 0 | 0 | 5 | 8 | 0 | 0 | 1 | 2 | 0 | 0 |
Pharyngitis | 6 | 10 | 0 | 0 | 6 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
Pruritus | 6 | 10 | 0 | 0 | 5 | 8 | 1 | 2 | 0 | 0 | 0 | 0 |
Dizziness | 5 | 8 | 1 | 2 | 3 | 5 | 0 | 0 | 1 | 2 | 0 | 0 |
Urinary tract infection | 5 | 8 | 0 | 0 | 3 | 5 | 2 | 3 | 0 | 0 | 0 | 0 |
Abdominal pain | 4 | 7 | 0 | 0 | 4 | 7 | 0 | 0 | 0 | 0 | 0 | 0 |
Serum sickness | 4 | 7 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 5 | 0 | 0 |
Anorexia | 4 | 7 | 1 | 2 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Injection site reaction | 3 | 5 | 1 | 2 | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 0 |
Constipation | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Gastritis | 3 | 5 | 0 | 0 | 2 | 3 | 1 | 2 | 0 | 0 | 0 | 0 |
Hypothyroidism | 3 | 5 | 0 | 0 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 |
Paresthesia | 3 | 5 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cough increased | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Rhinitis | 3 | 5 | 0 | 0 | 2 | 3 | 1 | 2 | 0 | 0 | 0 | 0 |
Sweating | 3 | 5 | 0 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 0 | 0 |
Conjunctivitis | 3 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
All adverse events that occurred in at least 5% of patients.